Colorectal News and Research

RSS

New method to estimate cancer survival

Cancer survival estimates are important to patients, physicians, clinical trials planning and resource allocation. Predictions by present statistical methods tend to lag behind current outcomes.

17 Apr 2006

Review examines the management of radiotherapy induced rectourethal fistula

Rectourethral fistulas (RUF) are a challenging problem observed by urological and colorectal surgeons.

11 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Research explains why recipients of growth hormone therapy may develop colon polyps

The use of growth hormone therapy has been linked in some people to the development of colon polyps, a possible precursor to colorectal cancer - but medical researchers have debated the extent of a cancer risk.

11 Apr 2006

Alcohol use, tobacco use and male gender associated with an earlier onset of colorectal cancer

Colorectal cancer is the second leading cause of cancer deaths, according to background information in the article. Screening asymptomatic patients is an important strategy for reducing these deaths, because by the time patients experience symptoms, the cancer may have progressed beyond the point where it can be cured.

11 Apr 2006

Protein loss linked to colon polyp risk from growth hormone

10 Apr 2006

Inflammation cuts both ways

Inflammation cuts both ways. When invaded by an infectious agent, for example, the body calls on the forces of inflammation to fight and defeat the intruder.

6 Apr 2006

New mechanism that initiates metastasis

Researchers have known for years that the enzyme MMP-9 plays a key role in the spread of colorectal cancer. Now, scientists at Jefferson Medical College in Philadelphia have found out how the enzyme helps initiate the process, known as metastasis.

4 Apr 2006

Panitumumab shows promise for patients with colorectal cancer

Results from a Phase III study of a new drug show promise for patients with colorectal cancer that has spread to other parts of the body, according to a study presented during the 97th Annual Meeting of the American Association for Cancer Research.

4 Apr 2006

Study demonstrates the importance of familial factors in the general development of cancer

Studying thousands of people, researchers at The University of Texas M. D. Anderson Cancer Center have documented a 25 percent increased risk of developing one of a number of cancers in first-degree relatives of lung cancer patients who have never smoked compared to families of people who neither smoke nor have lung cancer.

4 Apr 2006

Most cancer victims unaware of anti-angiogenesis

According to a new survey nine out of ten patients battling cancer in Europe have never heard of the major breakthrough in cancer treatment, known as anti-angiogenesis.

From The University of Manchester 28 Mar 2006

Earlier onset of colorectal cancer associated with alcohol use, tobacco use and male gender

Colorectal cancer is the second leading cause of cancer death in the United States yet it is one of the most preventable forms of the disease.

28 Mar 2006

Determining the risk of ovarian malignancy in postmenopausal women with abnormal findings in the PLCO screening trial

Reporting on the largest study of its kind today at the Society of Gynecologic Oncologists 37th Annual Meeting on Women's Cancer, researchers presented new criteria for detecting ovarian cancer malignancy in postmenopausal asymptomatic women, 55 to 74 years old.

28 Mar 2006

New research suggests it may be possible to separate the anticancer properties of vitamin D

At the right dose, vitamin D is important for bone development and may help protect against the development of several cancers, particularly colorectal cancer.

21 Mar 2006

African American women urged to confront colorectal cancer

Despite having the greatest risk of developing and dying from colorectal cancer (CRC) of any gender, race or ethnicity, an astounding 96 percent of African American women do not consider themselves to be at high risk for the disease, according to a new Harris poll.

17 Mar 2006

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy.

15 Mar 2006

Lilly launches phase III trial of Enzastaurin

One of the deadliest and rarest forms of cancer is the focus of a Phase III study initiated by Eli Lilly and Company today.

9 Mar 2006

FDA gives greenlight for new treatment of head and neck cancer

The U.S. Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed the drug prolonged survival by 20 months.

5 Mar 2006

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

A new study shows that patients whose colorectal cancer has spread to the liver who received an approach called hepatic arterial infusion (HAI) - the administration of chemotherapy directly to the liver through a pump in the abdomen - fare better than those who received traditional, intravenous chemotherapy.

1 Mar 2006

New FDA approved mobile electron-beam system increases survival rates of women with advanced rectal cancer

Colorectal cancer is widely considered a man's disease, but actually affects an equal number of women and men. Detected early, it is highly curable in both genders, with survival rates approaching 90 percent. But if the cancer is detected at a more advanced stage, the outlook is often dismal.

27 Feb 2006

Colorectal News and Research

New method to estimate cancer survival

Review examines the management of radiotherapy induced rectourethal fistula

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

Research explains why recipients of growth hormone therapy may develop colon polyps

Alcohol use, tobacco use and male gender associated with an earlier onset of colorectal cancer

Protein loss linked to colon polyp risk from growth hormone

Inflammation cuts both ways

New mechanism that initiates metastasis

Panitumumab shows promise for patients with colorectal cancer

Study demonstrates the importance of familial factors in the general development of cancer

Most cancer victims unaware of anti-angiogenesis

Earlier onset of colorectal cancer associated with alcohol use, tobacco use and male gender

Determining the risk of ovarian malignancy in postmenopausal women with abnormal findings in the PLCO screening trial

New research suggests it may be possible to separate the anticancer properties of vitamin D

African American women urged to confront colorectal cancer

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy

Lilly launches phase III trial of Enzastaurin

FDA gives greenlight for new treatment of head and neck cancer

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

New FDA approved mobile electron-beam system increases survival rates of women with advanced rectal cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News